499 related articles for article (PubMed ID: 2996919)
1. Noncontraceptive estrogen use and cardiovascular disease.
Bush TL; Barrett-Connor E
Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
[TBL] [Abstract][Full Text] [Related]
2. The adverse effects of hormonal therapy.
Bush TL
Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
[TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
5. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
6. [Women and ischemic cardiopathy].
Assmann G; Davignon J; Fernández Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
Rev Clin Esp; 1989 Oct; 185(6):308-15. PubMed ID: 2695994
[TBL] [Abstract][Full Text] [Related]
7. [Hormone substitution in the menopause: effect on lipids and cardiovascular risk].
Keller U
Schweiz Rundsch Med Prax; 1991 Apr; 80(16):413-7. PubMed ID: 2038637
[TBL] [Abstract][Full Text] [Related]
8. [Oral contraceptives and metabolic changes].
Lara Ricalde R; Aznar Ramos R
Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
[TBL] [Abstract][Full Text] [Related]
9. Arteriosclerosis risk. The roles of oral contraceptives and postmenopausal estrogens.
Knopp RH
J Reprod Med; 1986 Sep; 31(9 Suppl):913-21. PubMed ID: 3772911
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerotic risk factors in cardiovascular disease.
LaRosa JC
J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
[TBL] [Abstract][Full Text] [Related]
11. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
[TBL] [Abstract][Full Text] [Related]
12. Atherogenesis: why women live longer than men.
Hazzard WR
Geriatrics; 1985 Jan; 40(1):42-51, 54. PubMed ID: 3965355
[TBL] [Abstract][Full Text] [Related]
13. Hormones and cardiovascular health in women.
ESHRE Capri Workshop Group
Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
[TBL] [Abstract][Full Text] [Related]
14. Lipid and lipoprotein changes in relation to oral contraception and hormonal replacement therapy.
Burkman RT
Fertil Steril; 1988 May; 49(5 Suppl 2):39S-50S. PubMed ID: 3282934
[TBL] [Abstract][Full Text] [Related]
15. [Estrogen therapy for the climateric and thromboembolic risk].
Campagnoli C; Prelato L; Rossetti MG
Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492
[TBL] [Abstract][Full Text] [Related]
16. Pill formulations and their effect on lipid and carbohydrate metabolism.
Brooks PG
J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
[TBL] [Abstract][Full Text] [Related]
18. The impact of estrogen on cardiovascular disease. Prospective studies: The Framingham Study.
Wilson PW
Postgrad Med; 1989 Apr; Spec No():51-3; discussion 89-90. PubMed ID: 2542911
[No Abstract] [Full Text] [Related]
19. Changes in lipoproteins with various sex steroids.
Teran AZ; Greenblatt RB; Chaddha JS
Obstet Gynecol Clin North Am; 1987 Mar; 14(1):107-19. PubMed ID: 3306515
[TBL] [Abstract][Full Text] [Related]
20. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
